Cardinal HealthLTS:0HTG 83 Buyback Yield % is 1.80 as of Jul. 04, 2026, which is 30% below its 10-year median of 2.56. GuruFocus rates LTS:0HTG with a GF Score™ of 83/100 and a GF Value™ of $141.65 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 40 Medical Distribution companies, Cardinal Health ranks better than 67.5% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Cardinal Health's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0HTG vs COR, MCK, HSIC: Buyback Yield % Comparison
For the Medical Distribution subindustry, Cardinal Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardinal Health Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cardinal Health's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Cardinal Health's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardinal Health (LTS:0HTG) has a Buyback Yield % of 1.80 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cardinal Health and its competitors. This is 30% below median its historical median of 2.56. Over the past decade, Cardinal Health's Buyback Yield % has ranged from 0.78 to 8.59. According to the industry distribution chart, Cardinal Health ranks #13 out of 40 companies in the Medical Distribution industry, placing it in the top 32.5%.
Is Cardinal Health's Buyback Yield % too high?
Cardinal Health's current Buyback Yield % of 1.80 is 30% below median its 10-year median of 2.56. Over the past 10 years, this metric has ranged from a low of 0.78 to a high of 8.59. The Medical Distribution industry median Buyback Yield % is 0.02. Cardinal Health's value of 1.80 is 8900% above this industry median. Based on the distribution chart, Cardinal Health ranks #13 out of 40 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Cardinal Health has a GF Score™ of 83/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's Buyback Yield % compare to COR and MCK?
According to the Medical Distribution industry distribution chart, Cardinal Health ranks #13 out of 40 companies for Buyback Yield %. This puts Cardinal Health in the upper half of its industry. The industry median Buyback Yield % is 0.02. Cardinal Health's value of 1.80 is 8900% above this benchmark. Historically, Cardinal Health's own Buyback Yield % has ranged from 0.78 to 8.59 over the past decade. While the company's 10-year median is 2.56 vs. the industry median of 0.02, Cardinal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.02, based on 40 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardinal Health's current Buyback Yield % of 1.80 is 8900% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cardinal Health and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardinal Health's current Buyback Yield % is 1.80, which is 30% below median its own 10-year median of 2.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (LTS:0HTG) is currently considered Significantly Overvalued. The stock's GF Value™ is $141.65, compared to a current price of $238.69 — trading 68.5% above its estimated fair value. The current Buyback Yield % is 1.80, which is 30% below median its 10-year median of 2.56 and 8900% above the Medical Distribution industry median of 0.02. Cardinal Health's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Cardinal Health (LTS:0HTG), the current Buyback Yield % is 1.80 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardinal Health (LTS:0HTG) Overvalued in 2026?
Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued.
The current stock price of $238.69 is trading 68.5% above its estimated GF Value™ of $141.65.
GuruFocus considers Cardinal Health to be Significantly Overvalued.
Key valuation signals for LTS:0HTG:
Buyback Yield %: 1.80 (30% below median its 10-year median of 2.56)
GF Value™: $141.65 vs. price of $238.69 (68.5% above fair value)
Industry Position: 8900% above the Medical Distribution median (#13 of 40)
No single metric tells the full story. See the LTS:0HTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
83GF Score
Get the complete analysis for LTS:0HTG
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0HTG has been successfully added to your 
